Pharmaceutical - GlaxoSmithKline

Filter

Current filters:

GlaxoSmithKline

Popular Filters

76 to 100 of 416 results

GSK and Theravance submit US sNDA for Breo Ellipta in asthma

GSK and Theravance submit US sNDA for Breo Ellipta in asthma

30-06-2014

US pharma giant GlaxoSmithKline and US partner Theravance have submitted a supplemental New Drug Application…

Breo ElliptaGlaxoSmithKlinePharmaceuticalRegulationRespiratory and PulmonaryTheravanceUSA

GSK comments on media coverage of China problems

GSK comments on media coverage of China problems

30-06-2014

UK pharma giant GlaxoSmithKline, already the subject of allegations and investigations of wrongful marketing…

ChinaGlaxoSmithKlineManagementMarkets & MarketingPharmaceutical

EU5 payers looking to superior clinical efficacy for COPD

EU5 payers looking to superior clinical efficacy for COPD

30-06-2014

Surveyed pulmonologists in the European Union (EU5; France, Germany, Italy, Spain and the UK) estimate…

EuropeGlaxoSmithKlineMarkets & MarketingPharmaceuticalRelvarRespiratory and Pulmonary

GSK and Genmab’s ofatumumab disappoints in Ph III CLL study

28-06-2014

UK pharma giant GlaxoSmithKline and Danish partner Genmab have revealed that the Phase III study of…

GenmabGlaxoSmithKlineOfatumumab InjectionOncologyPharmaceutical

Another $1 million GSK milestone for Isis Pharma

Another $1 million GSK milestone for Isis Pharma

24-06-2014

USA-based Isis Pharmaceuticals said today that it has earned a $1 million milestone payment from GlaxoSmithKline…

FinancialGlaxoSmithKlineIsis PharmaceuticalsISIS-TTR RxPharmaceuticalRare diseasesResearch

EHA 2013: GSK announces results of Phase III PETIT2 study of eltrombopag

EHA 2013: GSK announces results of Phase III PETIT2 study of eltrombopag

16-06-2014

UK pharma major GlaxoSmithKline announced the results from the Phase III PETIT2 study evaluating the…

eltrombopagEuropeGlaxoSmithKlineHealth Medical PharmaHematologyItalyMajorMedicinePharmaceuticalResearchThrombocytopenic purpura

ADA 2014: GSK presents new data for once-weekly Tanzeum in type 2 diabetes

ADA 2014: GSK presents new data for once-weekly Tanzeum in type 2 diabetes

15-06-2014

Patients enrolled in of four randomized Phase III studies who remained on Tanzeum/Eperzan (albiglutide),…

Anti-diabetic drugsDiabetesGlaxoSmithKlineGSKMajorPharmaceuticalResearchStudy protocolStudy protocolTanzeumUK

GSK’s eltrombopag performs well in Phase III PETIT2 study

GSK’s eltrombopag performs well in Phase III PETIT2 study

13-06-2014

UK pharma major GlaxoSmithKline has announced positive results from the Phase III PETIT2 study evaluating…

eltrombopagGlaxoSmithKlineOncologyPharmaceuticalResearchThrombocytopenic purpuraUK

Positive data on Incruse Ellipta added to Relvar/Breo Ellipta in COPD

Positive data on Incruse Ellipta added to Relvar/Breo Ellipta in COPD

11-06-2014

UK pharma giant GlaxoSmithKline and US partner Theravance have released positive results from two Phase…

Breo ElliptaGlaxoSmithKlineIncruse ElliptaPharmaceuticalRelvar ElliptaResearchRespiratory and PulmonaryTheravance

GSK launches Phase III trial with losmapimod in acute coronary syndrome

GSK launches Phase III trial with losmapimod in acute coronary syndrome

06-06-2014

UK pharma major GlaxoSmithKline has announced the start of a pivotal Phase III study, LATITUDE-TIMI 60,…

Cardio-vascularCardiologyGlaxoSmithKlinelosmapimodPharmaceuticalResearchUK

US retinal specialists very receptive to pipeline agents for dry-AMD

US retinal specialists very receptive to pipeline agents for dry-AMD

05-06-2014

Surveyed US retinal specialists are highly willing to prescribe key emerging therapies for the treatment…

emixustatGlaxoSmithKlineGSK-933776Markets & MarketingOphthalmicsOtsukaPharmaceuticalResearchUSA

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

05-06-2014

UK pharma giant GlaxoSmithKline has agreed to a $105 million settlement with 44 US states and the District…

AdvairFinancialGlaxoSmithKlineLegalMarkets & MarketingNeurologicalPaxilPharmaceuticalRespiratory and PulmonaryUSAWellbutrin

GSK begins to seek bids for its established products portfolio

GSK begins to seek bids for its established products portfolio

30-05-2014

UK pharma major GlaxoSmithKline has taken the first steps to divest some of its products in a bid to…

FinancialGlaxoSmithKlinePharmaceuticalUK

GlaxoSmithKline now faces UK SFO inquiry into commercial practices

GlaxoSmithKline now faces UK SFO inquiry into commercial practices

28-05-2014

UK pharma giant GlaxoSmithKline, already subject to allegations of bribery of doctors and hospitals in…

GlaxoSmithKlineLegalMarkets & MarketingPharmaceuticalUK

IQWIG finds added benefit in adult patients for VIIV Healthcare’s Tivicay

27-05-2014

In an early benefit assessment under the Act on the Reform of the Market for Medicinal Products (AMNOG),…

Anti-viralsGermanyGlaxoSmithKlinePharmaceuticalPricingRegulationTivicayViiV Healthcare

GSK commits to five-year vaccine price freeze for countries graduating from GAVI Alliance support

22-05-2014

UK pharma giant GlaxoSmithKline has said it will freeze the prices of its vaccines for a period of five…

GlaxoSmithKlineGlobalPharmaceuticalPricingVaccines

GSK and Genmab reveal disappointing Ph III data with ofatumumab + chemo in B-cell lymphoma

20-05-2014

UK Pharma major GlaxoSmithKline and Denmark’s Genmab revealed yesterday that the Phase III ORCHARRD…

GenmabGlaxoSmithKlineOfatumumab InjectionOncologyPharmaceuticalResearch

GlaxoSmithKline now accused of tax evasion in China

19-05-2014

The Legal Daily, the official newspaper of the Chinese Ministry of Justice, on Friday accused UK pharma…

ChinaFinancialGlaxoSmithKlineLegalPharmaceutical

GlaxoSmithKline divests rights to Treximet to Pernix for $250 million

15-05-2014

UK pharma giant GlaxoSmithKline will divest all of its rights to migraine drug Treximet (sumatriptan/naproxen…

GlaxoSmithKlineLicensingNeurologicalPernix TherapeuticsPharmaceuticalPozenTreximetUSA

Police close investigation on GlaxoSmithKline China's bribery case

Police close investigation on GlaxoSmithKline China's bribery case

14-05-2014

Chinese police have finished the investigation on the suspected bribery case of the local subsidiary…

ChinaGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

Another disappointment for GlaxoSmithKline with darapladib

Another disappointment for GlaxoSmithKline with darapladib

13-05-2014

UK Pharma giant GlaxoSmithKline today announced disappointing headline results from its second Phase…

Cardio-vasculardarapladibGlaxoSmithKlinePharmaceuticalResearch

GlaxoSmithKline and Theravance’s Anoro Ellipta gains approval in EU

GlaxoSmithKline and Theravance’s Anoro Ellipta gains approval in EU

09-05-2014

The European Commission has granted marketing authorization for UK pharma giant GlaxoSmithKline and partner…

Anoro ElliptaEuropeGlaxoSmithKlinePharmaceuticalRegulationRespiratory and PulmonaryTheravance

76 to 100 of 416 results

COMPANY SPOTLIGHT

Menarini

Back to top